Search results
US FDA advisers to consider if new COVID shots should target JN.1 variant By Reuters
Investing.com· 3 days agoThe company had said last month it would only be able to offer a COVID vaccine in the United States...
US FDA advisers to consider if new COVID shots should target JN.1 variant
AOL· 3 days agoThe FDA reviewers said since the difference between JN.1 and newer subvariants such as KP.2 subvariants is not much, it is possible that vaccines developed against JN.1 may adequately protect against KP.2.
FDA approves Moderna’s mRNA RSV vaccine for older adults - ABC17NEWS
ABC17 NEWS· 5 days agoThe shot, made by Moderna and sold under the name of mResvia, could be another tool in the country’s RSV arsenal in the fall. Moderna’s shot is the third RSV vaccine for people 60 and older ...
Where have mosquitos tested positive for West Nile virus in DFW -- so far?
WFAA Dallas-Fort Worth· 6 days agoSummer has officially started and mosquito season is here too. At least four cities have reported a...
FDA Approves First mRNA RSV Vaccine
MedPage Today· 6 days agoThe FDA approved the first-ever mRNA-1345 vaccine (mRESVIA) for respiratory syncytial virus (RSV) for people ages 60 and older to protect against lower...
FDA Roundup: May 31, 2024
The Woonsocket Call· 5 days agoToday, the FDA approved mRESVIA (Respiratory Syncytial Virus Vaccine) for the prevention of lower respiratory tract disease (LRTD) caused by respiratory ...
US FDA advisers to consider if new COVID shots should target JN.1 variant
Reuters via Yahoo News· 3 days agoThe company had said last month it would only be able to offer a COVID vaccine in the United States...
FDA approves Moderna's RSV shot for older adults
Becker’s Hospital Review· 3 days agoThe FDA has given the green light to Moderna's mRNA-based respiratory syncytial virus vaccine, specifically for older adults, the drugmaker announced May ...
Moderna Scores FDA Approval For Its Second Product - Respiratory Syncytial Virus Vaccine
Benzinga· 5 days agoOn Friday, the FDA approved Moderna Inc’s MRNA mRESVIA (mRNA-1345), an mRNA respiratory syncytial virus (RSV) vaccine to protect adults aged 60 and older ...
FDA urged to relax decades-old tissue donation restrictions for gay and bisexual men
Denver Post· 4 days agoBut such windows are now quite narrow. Researchers with the Centers for Disease Control.... He said...
